Santhera Pharmaceuticals Holding AG

SIX:SANN.SW

8.42 (CHF) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 14.1147.05799.43749.7193.9391.971.2230.6126.253.125-6.087-3.0444.4922.2467.2333.6177.7753.88857.06128.53118.3159.1588.0237.6078.0148.0146.5965.4885.435.435.9125.9123.6053.6051.4331.4330.7280.7280.8810.8810.4150.4150.0960.0960.5640.5640.9210.921
Cost of Revenue 2.6082.6081.6360.6542.2340.9642.0280.8592.1720.9382.0460.8682.4051.01611.5784.1592.9511.0573.7641.4473.4181.2791.0961.1661.2211.2211.0761.0740.9770.9770.9860.9860.9560.9560.6060.6060.080.080.0620.0620.0380.0380.0070.0070.0640.0641.2421.242
Gross Profit 11.5074.4597.80149.0651.7051.006-0.805-0.2474.0782.188-8.133-3.9122.0871.231-4.345-0.5424.8242.83153.29727.08414.8977.8796.9276.4416.7936.7935.524.4144.4534.4534.9264.9262.652.650.8270.8270.6480.6480.8190.8190.3770.3770.090.090.50.5-0.322-0.322
Gross Profit Ratio 0.8150.6310.9840.9870.4330.511-0.658-0.4040.6520.71.3361.2850.4650.548-0.601-0.150.620.7280.9340.9490.8130.860.8630.8470.8480.8480.8370.8040.820.820.8330.8330.7350.7350.5770.5770.8910.8910.930.930.910.910.9320.9320.8870.887-0.349-0.349
Reseach & Development Expenses 6.8866.8868.9264.4639.7484.87413.6666.83316.878.43516.1238.06213.5926.79616.548.2717.6888.84421.91910.9619.3259.66311.1428.2449.4279.4278.3936.4655.8525.8524.7874.7874.0514.0513.7953.7951.4321.4321.9821.9820.9570.9570.7770.7771.5781.57812.60812.608
General & Administrative Expenses 4.1334.1336.4176.4174.1764.1763.7163.7163.5673.5673.2093.2093.1543.1542.6162.6163.6053.6055.9895.9893.6033.6034.0733.2414.0264.0264.8433.463.0573.0572.1632.1632.742.742.5562.5561.5671.5671.3031.3030.8950.8950.5310.5311.0241.0240.8240.824
Selling & Marketing Expenses 2.332.332.7632.7632.1292.1293.523.521.9091.9093.6623.6621.0041.0042.3542.3543.3833.3834.2434.2435.8065.8066.2475.7166.4616.4618.6137.2876.3116.3116.0516.0514.4754.4753.4113.4110.7680.7680.2120.2120.0790.0790.0860.0860.3770.3770.3620.362
SG&A 6.4636.46318.0299.17912.3026.3045.8517.23612.7535.47513.4326.8717.9414.1576.6784.9713.1386.98819.59210.23217.9569.40910.328.95710.48610.48613.45610.7479.3689.3688.2148.2147.2147.2145.9665.9662.3342.3341.5141.5140.9740.9740.6170.6171.4011.4011.1861.186
Other Expenses -0.028-0.028-9.1330000000000000000000-0.2820.11100-0.031-0.00800000000000000000000
Operating Expenses 13.3213.3226.9552.73522.058.70719.51714.57829.62312.57729.55510.78221.5335.68423.21815.22530.82617.34841.51121.35737.28119.76721.1817.31219.94219.94221.81817.20415.14415.14412.91412.91411.25311.2533.7523.7523.7563.7563.2513.2511.9191.9191.1921.1922.272.2712.51912.519
Operating Income -8.871-8.87170.84635.714-20.345-10.153-20.322-11.165-25.545-11.718-37.688-18.706-19.446-9.739-27.563-13.592-26.002-12.94711.7865.996-22.384-11.217-14.253-10.871-13.149-13.149-16.298-12.79-10.683-10.683-7.96-7.96-8.604-8.604-8.384-8.384-3.108-3.108-2.426-2.426-1.542-1.542-0.981-0.981-2.401-2.401-2.865-2.865
Operating Income Ratio -0.628-1.2570.7120.718-5.165-5.155-16.617-18.258-4.087-3.756.1926.146-4.329-4.336-3.811-3.758-3.344-3.330.2070.21-1.222-1.225-1.777-1.429-1.641-1.641-2.471-2.331-1.968-1.968-1.347-1.347-2.387-2.387-5.851-5.851-4.272-4.272-2.754-2.754-3.719-3.719-10.219-10.219-4.261-4.261-3.112-3.112
Total Other Income Expenses Net 1.3261.3267.394-5.454-3.075-1.558-21.162-7.522-3.587-1.7982.8371.28-0.42-0.195-8.427-4.404-5.464-2.787-3.681-1.944-4.115-2.033-0.068-1.415-0.481-0.481-0.7491.217-0.645-0.645-0.076-0.0760.0430.043-0.039-0.039-0.081-0.081-0.003-0.003-0.005-0.005-0.01-0.010.7850.785-9.981-9.981
Income Before Tax -7.545-7.54578.24139.121-23.42-11.71-41.484-20.742-29.132-14.566-34.851-17.426-19.866-9.933-35.99-17.995-31.466-15.7338.1054.053-26.499-13.25-14.321-12.285-13.629-13.629-17.047-11.573-11.328-11.328-8.036-8.036-8.561-8.5614.6564.656-3.189-3.189-2.429-2.429-1.547-1.547-1.264-1.264-1.617-1.617-12.846-12.846
Income Before Tax Ratio -0.535-1.0690.7870.787-5.946-5.946-33.92-33.92-4.661-4.6615.7255.725-4.423-4.423-4.976-4.976-4.047-4.0470.1420.142-1.447-1.447-1.785-1.615-1.701-1.701-2.584-2.109-2.086-2.086-1.359-1.359-2.375-2.3753.2493.249-4.384-4.384-2.757-2.757-3.731-3.731-13.161-13.161-2.869-2.869-13.955-13.955
Income Tax Expense 0.0870.0870.1230.062-0.0840.042-0.1320.0660.5920.2960.1560.0780.6530.327-0.1580.0790.3610.1810.1780.0890.4010.201-0.0580.2870.0470.0471.152-0.9520.0290.0290.6860.6860.4250.4251.5091.5090.0010.0010.0010.0010.0010.0010.0010.0010.0040.0040.1440.144
Net Income -7.632-7.63278.11839.059-23.336-11.668-41.352-20.676-29.724-14.862-35.007-17.504-20.519-10.26-35.832-17.916-31.827-15.9147.9273.964-26.9-13.45-14.263-12.572-13.676-13.676-18.199-10.621-11.356-11.356-8.722-8.722-8.986-8.9866.1656.165-3.19-3.19-2.429-2.429-1.547-1.547-1.265-1.265-1.613-1.613-12.99-12.99
Net Income Ratio -0.541-1.0810.7860.786-5.924-5.924-33.812-33.812-4.756-4.7565.7515.751-4.568-4.568-4.954-4.954-4.094-4.0940.1390.139-1.469-1.469-1.778-1.653-1.707-1.707-2.759-1.935-2.092-2.092-1.475-1.475-2.493-2.4934.3024.302-4.385-4.385-2.757-2.757-3.732-3.732-13.172-13.172-2.862-2.862-14.111-14.111
EPS -0.67-0.6773.5-2.09-1.05-6.43-3.18-5.24-2.62-7.06-3.8-9.22-4.61-23.01-11.8-27.8-13.97.133.57-24.7-12.35-17.36-1.94-21.25-21.25-28.97-1.69-18.1-18.1-13.9-13.9-14.35-14.3510.2810.28-6.4-6.4-4.87-4.87-3.5-3.5-3.37-3.37-4.4-4.4-35.25-35.25
EPS Diluted -0.67-0.6773.5-2.09-1.05-6.43-3.17-5.24-2.62-7.06-3.8-9.22-4.61-23.01-11.8-27.8-13.97.133.57-24.7-12.35-17.36-1.94-21.25-21.25-28.97-1.69-18.1-18.1-13.88-13.88-14.35-14.3510.310.3-6.4-6.4-4.87-4.87-3.5-3.5-3.37-3.37-4.4-4.4-35.25-35.25
EBITDA -7.484-7.48492.75236.322-13.578-9.24-27.817-10.47-18.962-10.81-27.556-18.004-7.014-8.792-26.75-13.039-26.678-11.76915.9676.601-20.395-10.027-13.425-9.601-12.204-12.204-15.515-9.257-9.85-9.85-7.166-7.166-7.794-7.794-7.855-7.855-3.088-3.088-2.413-2.413-1.522-1.522-0.971-0.971-2.116-2.116-2.829-2.829
EBITDA Ratio -0.53-1.0610.7250.731-4.702-4.692-15.119-17.121-3.797-3.4595.8915.915-3.908-3.915-3.15-3.605-3.041-3.0270.2480.231-1.092-1.095-1.761-1.262-1.523-1.523-2.417-1.687-1.814-1.814-1.212-1.212-2.162-2.162-5.482-5.482-4.245-4.245-2.738-2.738-3.672-3.672-10.109-10.109-3.754-3.754-3.073-3.073